Loading clinical trials...
Loading clinical trials...
Optimized Therapy of Decompensated Liver Cirrhosis by Hemodynamic Monitoring Using the PiCCO System
Prospective comparison of standard therapy in liver cirrhosis versus standard therapy plus intensified hemodynamic monitoring using the PiCCO system.
Patients presenting with advanced liver cirrhosis will receive either standard treatment or standard treatment plus hemodynamic monitoring with the PiCCO device. Fluids and vasoacitve drugs will be administered according to the measurements over a period of 5 days.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
University of Heidelberg, Clinical center
Heidelberg, Germany
Start Date
August 1, 2005
Completion Date
August 1, 2007
Last Updated
October 3, 2007
20
ACTUAL participants
Hemodynamic monitoring system PiCCO
PROCEDURE
Lead Sponsor
Heidelberg University
NCT06169592
NCT07275554
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions